Executive Directors
XU Tiefeng (Chairman)
YANG Bin (Managing Director)
SITU Min (Chief Financial Officer)
Non-executive Director
DU Richeng
Independent Non-executive Directors
LO Wing Yat
PANG Fu Keung
WANG Bo
ZHANG Jianhui
Executive Directors
XU Tiefeng, aged 57, was appointed to the Board on 10 June 2009. Mr. XU is the Chairman of the Board since 28 March 2012. Mr. XU obtained a college diploma in political economy from Guangdong Provincial Party School ( 廣 東 黨 校 ) in 1987 and had worked for over 15 years in the government departments and organisations in the People's Republic of China (the "PRC"). During 1984 to 1999, he acted as the Deputy Supervisor ( 副 鎮 長 ) and Supervisor( 鎮 長 ) of the former Shunde Rongqi Municipal Government ( 佛 山 市 順 德 區 容 奇 鎮 人 民 政 府 ) (the "Rongqi Government"), Deputy Director ( 副 主 任 ) of Office of Industry Development of the Rongqi Government ( 順 德 容 奇 鎮 政 府 工 業 辦 公 室 ) and Secretary of the Rongqi Government. Mr. XU was responsible principally for industrial and economy development and overseeing the development of local state-owned industrial and technology enterprises in Shunde District, covering a wide range of industries including manufacturing of electrical appliances, electronic products, animal feed and pharmaceutical products, and software development. He was actively involved in introducing international practices and management models to local enterprises as well as promoting corporate activities such as mergers and acquisitions and listings for local enterprises. Mr. XU had during that period taken up various roles in companies under the control of the Rongqi Government to represent the controlling interests of the Rongqi Government, including acting as the General Manager of Rongqi Town Economic Development Corporation ( 容 奇 經 濟 發 展 總 公 司 ) and Rongqi Investment Holding Company ( 容 奇 經 濟 發 展 總 公 司 ), and a director of Guangdong Kelon (Rongsheng) Group Company Limited ( 廣 東 科 龍 （ 容 聲 ） 集 團 有 限 公 司 ) and Guangdong Kelon Electrical Holdings Company Limited 廣 東 科 龍 電 器 股 份 有 限 公 司 ("Kelon"). Kelon (now known as Hisense Kelon Electrical Holdings Company Limited ( 海 信 科 龍 電 器 股 份 有 限 公 司 ) is a joint stock limited company incorporated in the PRC whose H shares are listed on the Main Board of the Stock Exchange (stock code: 921) and whose A shares are listed on The Stock Exchange of Shenzhen, the PRC.
YANG Bin, aged 44, was appointed to the Board on 6 February 2009. Mr. YANG was the Managing Director of the Company with effect from 11 February 2009. Mr. YANG graduated from 中央民族大學 (Minzu University of China) majoring in Biochemistry. Mr. YANG engaged in research and development of new products in 佛山市醫藥總公司 (Foshan City Medical Corporation), and served as the Deputy General Manager of 佛山市醫藥銷售有限公司 (Foshan City Medical Sale Co., Ltd.), director of 佛山市生物化學製藥廠 (Foshan City Biochemical Pharmaceutical Factory) and General Manager of 佛山市華衛醫藥有限公司 (Foshan City Huawei Medical Co., Ltd.). Mr. YANG has 20 years of experience in registration of medicines and drugs, research and development and sale of medical products. He had successfully launched a series of new products with good response from the market and enjoys high reputation in the sales market. Mr.YANG is currently the Chairman and a director of 廣東環球 (Guangdong Medi-World), 山東魯亞製藥有限公司 (Shandong Luya Pharmaceutical Co., Ltd.) and 佛山盈天醫藥科技有限公司 (Foshan Winteam Medical Technology Company Limited).
SITU Min, aged 42, was appointed to the Board in September 2001. Mr. SITU is the Chief Financial Officer and the Qualified Accountant of the Company. Mr. SITU is mainly responsible for the Group's financial disclosure, acquisitions and reorganisations, investor relations. He is a fellow member of the Association of Chartered Certified Accountants and is also a member of Chinese Institute of Certified Public Accountants. Mr. SITU has extensive experience in financial management, and corporate finance and acquisitions.
Non-executive Director
DU Richeng, aged 62, was appointed to the Board as a non-executive director in January 2008 and is also a member of the Company's remuneration committee. Mr. DU was the Chairman of the Board for 5 years. Now, Mr. DU remains as a non-executive director of the Company since 28 March 2012. Mr. DU has over 30 years' experience in international trading, industrial management, property development and public utilities. Mr. DU was an executive director of the Company from 14 April 1998 to 8 February 2001. Mr. DU came to work in Hong Kong in March 1990 and was appointed as the vice chairman and managing director of Foshan Development Company Limited in November 1996. Subsequently, he was appointed as the chairman of 佛 山 電 建 集 團 公 司 (Foshan Electric Power Construction Group Corporation) on his return to the mainland China in January 2001 and was re-designated as the chairman of 佛 山 公 用 事 業 控 股 有 限 公 司 (Foshan Public Utilities Holding Co., Ltd.) (ˇ§Foshan Public Utilitiesˇ¨) in July 2006 and had held such office until December 2008. Mr. DU also served as a 調 研 員 (senior consultant) of Foshan Public Utilities until December 2012.
Independent Non-executive Directors
LO Wing Yat, aged 53, was appointed to the Board on 11 February 2009. Mr. LO is the Executive Vice Chairman and Chief Executive Officer of CIAM Group Limited (Stock Code: 378), whose shares are listed on the Stock Exchange. He is also the Chief Executive Officer of CITIC International Assets Management Limited and the Managing Director of CITIC International Financial Holdings Limited. Mr. LO also serves as a director in numerous Hong Kong listed companies. He is an executive director of Thunder Sky Battery Limited (Stock Code: 729) and a non-executive director of China Fortune Holdings Limited (Stock Code: 110). He formerly served as a non-executive director of Longlife Group Holdings Limited (Stock Code: 8037) till April 2010. Mr. LO graduated from The University of Hong Kong with a bachelor's degree in Laws. He was admitted as a solicitor of the Supreme Court of Hong Kong in 1984 and a solicitor of the Supreme Court of England and Wales in 1989. He served as an in-house counsel of Bank of China Hong Kong-Macau Regional Office and a partner of Linklaters. During his legal career, Mr. LO was specialised in banking project financing primarily in the PRC.
PANG Fu Keung, aged 40, was appointed to the Board on 11 February 2009. Mr. PANG is the Senior Investment Professional - TRG Management Hong Kong Limited (known as The Rohatyn Group) and Head of the China Special Investments. Mr. PANG was also a director of Citigroup's Global Special Situations Group responsible for Greater China distressed assets, NPL portfolios, pre-IPO and growth equity. Mr. PANG formerly worked for KPMG's Financial Advisory Services as a corporate restructuring specialist. Mr. PANG has extensive experience in assurance, corporate finance and corporate restructuring work and has assisted a number of listed companies in Hong Kong and the PRC since mid-1990s. Mr. PANG graduated from the University of New South Wales in Australia and is a member of the CPA Australia and fellow member of the Hong Kong Institute of Certified Public Accountants. Mr. PANG is also a member of The Hong Kong Institute of Directors.
WANG Bo, aged 52, was appointed to the Board on 10 June 2009. Mr. WANG graduated from Beijing Institute of Iron and Steel Metallurgy Machinery. Mr. WANG had been Deputy Director of Design and Research Institute of Beijing Nonferrous Metallurgy, General Manager of Beijing Bodi Computer Software Technology Co., Ltd. and General Manager of Beijing Online Software Technology Co., Ltd. Mr. WANG is currently President of 北京秦脉醫藥科技發展有限公司 (Beijing Qinmai Pharmaceutical Technology Development Co., Ltd.) and Chairman of 北京秦脉醫藥諮詢有限公司 (Beijing Qinmai Pharmaceutical Consultant Co., Ltd.). Mr. WANG is also the independent director of Beijing Double Crane Pharmaceutical Co Ltd which is listed in the PRC (stock code: 600062) and Jiangsu Wu Zhong Shi Ye Company Limited which is listed in the PRC (stock code: 600200). Additional, Mr. WANG is also Vice Chairman of 中國醫藥企業管理協會 (Chinese Pharmaceutical Enterprises Association) and Vice Chairman of 全國醫藥技術市場協會 (National Pharmaceutical Technology Market Association). Mr. WANG has 18 years of experience in pharmaceutical policy research and pharmaceutical manufacturing consultancy.
ZHANG Jianhui, aged 66, was appointed to the Board on 10 June 2009. Mr. ZHANG graduated from Institute of Chemical Engineering, Faculty of Biochemistry of Zhejiang University. Mr. ZHANG is a senior engineer and licensed pharmacist. Mr. ZHANG has 40 years of experience in management of pharmaceutical manufacturing and has obtained the National Technological Advancement Third Class Award. Mr. ZHANG is entitled to the Special Allowance from State Council and is an Excellent Talent of the Professional Technique in the Shandong Province. Mr. ZHANG had been Chairman of Shandong Lukang Pharmaceutical Group and Chairman of Shandong Lukang Pharmaceutical Co., Ltd. (listed on Shanghai Stock Exchange, stock code: 600789). Mr. ZHANG is currently appointed as Deputy Director of the 中國化學制藥工業協會專家委員會 (Specialist Committee of China Pharmaceutical Industry Association) and Consultant of 山東省醫藥工業協會顧問 (Shandong Pharmaceutical Industry Association).
updated 2nd April, 2012
| © Copyright 1996-2012 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |